Literature DB >> 20813317

Image-guided radiofrequency ablation for the treatment of early-stage non-small cell lung neoplasm in high-risk patients.

Arjun Pennathur1, Ghulam Abbas, Matthew J Schuchert, Rodney J Landreneau, James D Luketich.   

Abstract

Lung cancer is the most common cause of cancer-related mortality in the United States. Surgical resection with a lobectomy is the standard treatment for stage I non-small cell lung cancer. With an aging population, however, there are a significant number of patients who have other comorbidities that preclude surgical resection. Image-guided radiofrequency ablation is a new emerging modality of treatment which may be applicable in this high-risk group of patients. In this article, we review the principles of radiofrequency ablation, the common devices in use, the results of ablate and resect studies, future directions, and the results of treatment for stage I non-small cell lung neoplasm. Copyright 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 20813317      PMCID: PMC4626887          DOI: 10.1053/j.semtcvs.2010.06.002

Source DB:  PubMed          Journal:  Semin Thorac Cardiovasc Surg        ISSN: 1043-0679


  30 in total

1.  Radiofrequency ablation of primary lung cancer: results from an ablate and resect pilot study.

Authors:  Christophe L Nguyen; Walter J Scott; Nancy A Young; Tina Rader; Lydia R Giles; Melvyn Goldberg
Journal:  Chest       Date:  2005-11       Impact factor: 9.410

2.  Randomized trial of lobectomy versus limited resection for T1 N0 non-small cell lung cancer. Lung Cancer Study Group.

Authors:  R J Ginsberg; L V Rubinstein
Journal:  Ann Thorac Surg       Date:  1995-09       Impact factor: 4.330

3.  Biologic effects of radiofrequency thermal ablation on non-small cell lung cancer: results of a pilot study.

Authors:  Marcello Carlo Ambrogi; Gabriella Fontanini; Roberto Cioni; Pinuccia Faviana; Olivia Fanucchi; Alfredo Mussi
Journal:  J Thorac Cardiovasc Surg       Date:  2006-05       Impact factor: 5.209

Review 4.  Microwave ablation: principles and applications.

Authors:  Caroline J Simon; Damian E Dupuy; William W Mayo-Smith
Journal:  Radiographics       Date:  2005-10       Impact factor: 5.333

5.  Radiotherapy alone for medically inoperable stage I non-small-cell lung cancer: the Duke experience.

Authors:  G S Sibley; T A Jamieson; L B Marks; M S Anscher; L R Prosnitz
Journal:  Int J Radiat Oncol Biol Phys       Date:  1998-01-01       Impact factor: 7.038

6.  Radiofrequency ablation for the treatment of non-small cell lung cancer in marginal surgical candidates.

Authors:  Hiran C Fernando; Alberto De Hoyos; Rodney J Landreneau; Sebastian Gilbert; William E Gooding; Percival O Buenaventura; Neil A Christie; Chandra Belani; James D Luketich
Journal:  J Thorac Cardiovasc Surg       Date:  2005-03       Impact factor: 5.209

7.  Pulmonary radiofrequency ablation: long-term safety and efficacy in 153 patients.

Authors:  Caroline J Simon; Damian E Dupuy; Thomas A DiPetrillo; Howard P Safran; C Alexander Grieco; Thomas Ng; William W Mayo-Smith
Journal:  Radiology       Date:  2007-04       Impact factor: 11.105

8.  Comparative study of three different catheters for CT imaging-bronchoscopy-guided radiofrequency ablation as a potential and novel interventional therapy for lung cancer.

Authors:  Tsuyoshi Tanabe; Tomonobu Koizumi; Kenji Tsushima; Michiko Ito; Shintaro Kanda; Takashi Kobayashi; Masanori Yasuo; Yoshitaka Yamazaki; Keishi Kubo; Takayuki Honda; Ryouichi Kondo; Kazuo Yoshida
Journal:  Chest       Date:  2009-10-26       Impact factor: 9.410

9.  Radiofrequency ablation for the treatment of stage I non-small cell lung cancer in high-risk patients.

Authors:  Arjun Pennathur; James D Luketich; Ghulam Abbas; Mang Chen; Hiran C Fernando; William E Gooding; Matthew J Schuchert; Sebastien Gilbert; Neil A Christie; Rodney J Landreneau
Journal:  J Thorac Cardiovasc Surg       Date:  2007-08-29       Impact factor: 5.209

10.  Radiotherapy alone in technically operable, medically inoperable, early-stage (I/II) non-small-cell lung cancer.

Authors:  Branislav Jeremic; Johannes Classen; Michael Bamberg
Journal:  Int J Radiat Oncol Biol Phys       Date:  2002-09-01       Impact factor: 7.038

View more
  5 in total

Review 1.  Emerging treatment options in the management of non-small cell lung cancer.

Authors:  Pier Luigi Filosso; Alberto Sandri; Alberto Oliaro; Andrea Riccardo Filippi; Maria Carla Cassinis; Umberto Ricardi; Paolo Olivo Lausi; Sofia Asioli; Enrico Ruffini
Journal:  Lung Cancer (Auckl)       Date:  2011-06-08

2.  Study of survival in patients with malignant lung lesions treated with radiofrequency.

Authors:  J M Galbis Caravajal; J Jornet Fayos; M Cuenca Torres; E Mollá Olmos; M Estors Guerrero; F Sánchez García; N J Martinez Hernandez; R Esturi Navarro; A Pastor del Campo; M Vaño Molina
Journal:  Clin Transl Oncol       Date:  2013-03-22       Impact factor: 3.405

3.  Percutaneous cryoablation for the treatment of medically inoperable stage I non-small cell lung cancer.

Authors:  Yoshikane Yamauchi; Yotaro Izumi; Kohei Hashimoto; Hideki Yashiro; Masanori Inoue; Seishi Nakatsuka; Taichiro Goto; Masaki Anraku; Takashi Ohtsuka; Mitsutomo Kohno; Masafumi Kawamura; Hiroaki Nomori
Journal:  PLoS One       Date:  2012-03-08       Impact factor: 3.240

4.  [Radiofrequency ablation for the treatment of lung neoplasms: a retrospective study of 329 cases].

Authors:  Qiang Lu; Xiaofei Li; Yong Han; Zhipei Zhang; Xiaolong Yan; Lijun Huang
Journal:  Zhongguo Fei Ai Za Zhi       Date:  2011-11

Review 5.  Cryoablation of early-stage primary lung cancer.

Authors:  Masanori Inoue; Seishi Nakatsuka; Masahiro Jinzaki
Journal:  Biomed Res Int       Date:  2014-06-04       Impact factor: 3.411

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.